Keywords: Forest Labs, USA, Health care contracts HHS, OIG, Carl Icahn, Litigation

Moves to bar Forest CEO from US health care contracts dropped by HHS-OIG

Article | 08 August 2011

Print This

In a week of high-profile activity for US drugmaker Forest Laboratories (NYSE: FRX), there was welcome news on Friday in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in